{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:02:37Z","timestamp":1792670557403,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"29","license":[{"start":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T00:00:00Z","timestamp":1489968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T00:00:00Z","timestamp":1489968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2017,7,20]]},"DOI":"10.1038\/onc.2017.46","type":"journal-article","created":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T17:14:25Z","timestamp":1490030065000},"page":"4161-4170","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Compromised BRCA1\u2013PALB2 interaction is associated with breast cancer risk"],"prefix":"10.1038","volume":"36","author":[{"given":"T K","family":"Foo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Tischkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Simhadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Boshari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Zayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K A","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S H","family":"Berman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Blecua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Riaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y C","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S L","family":"Neuhausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Weigelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J S","family":"Reis-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W D","family":"Foulkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,20]]},"reference":[{"key":"BFonc201746_CR1","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.cub.2009.02.018","volume":"19","author":"F Zhang","year":"2009","unstructured":"Zhang F, Ma J, Wu J, Ye L, Cai H, Xia B et al. PALB2 links BRCA1 and BRCA2 in the DNA-damage response. Curr Biol 2009; 19: 524\u2013529.","journal-title":"Curr Biol"},{"key":"BFonc201746_CR2","doi-asserted-by":"publisher","first-page":"7155","DOI":"10.1073\/pnas.0811159106","volume":"106","author":"SM Sy","year":"2009","unstructured":"Sy SM, Huen MS, Chen J . PALB2 is an integral component of the BRCA complex required for homologous recombination repair. Proc Natl Acad Sci USA 2009; 106: 7155\u20137160.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc201746_CR3","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1158\/1541-7786.MCR-09-0123","volume":"7","author":"F Zhang","year":"2009","unstructured":"Zhang F, Fan Q, Ren K, Andreassen PR . PALB2 functionally connects the breast cancer susceptibility proteins BRCA1 and BRCA2. Mol Cancer Res 2009; 7: 1110\u20131118.","journal-title":"Mol Cancer Res"},{"key":"BFonc201746_CR4","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.molcel.2006.05.022","volume":"22","author":"B Xia","year":"2006","unstructured":"Xia B, Sheng Q, Nakanishi K, Ohashi A, Wu J, Christ N et al. Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol Cell 2006; 22: 719\u2013729.","journal-title":"Mol Cell"},{"key":"BFonc201746_CR5","doi-asserted-by":"publisher","first-page":"7353","DOI":"10.1158\/0008-5472.CAN-10-1012","volume":"70","author":"M Tischkowitz","year":"2010","unstructured":"Tischkowitz M, Xia B . PALB2\/FANCN: recombining cancer and Fanconi anemia. Cancer Res 2010; 70: 7353\u20137359.","journal-title":"Cancer Res"},{"key":"BFonc201746_CR6","doi-asserted-by":"publisher","first-page":"18032","DOI":"10.1073\/pnas.1115052108","volume":"108","author":"T Walsh","year":"2011","unstructured":"Walsh T, Casadei S, Lee MK, Pennil CC, Nord AS, Thornton AM et al. Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. Proc Natl Acad Sci USA 2011; 108: 18032\u201318037.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc201746_CR7","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa1400382","volume":"371","author":"AC Antoniou","year":"2014","unstructured":"Antoniou AC, Casadei S, Heikkinen T, Barrowdale D, Pylkas K, Roberts J et al. Breast-cancer risk in families with mutations in PALB2. N Engl J Med 2014; 371: 497\u2013506.","journal-title":"N Engl J Med"},{"key":"BFonc201746_CR8","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1038\/embor.2009.126","volume":"10","author":"AW Oliver","year":"2009","unstructured":"Oliver AW, Swift S, Lord CJ, Ashworth A, Pearl LH . Structural basis for recruitment of BRCA2 by PALB2. EMBO Rep 2009; 10: 990\u2013996.","journal-title":"EMBO Rep"},{"key":"BFonc201746_CR9","doi-asserted-by":"publisher","first-page":"10312","DOI":"10.1093\/nar\/gks807","volume":"40","author":"R Buisson","year":"2012","unstructured":"Buisson R, Masson JY . PALB2 self-interaction controls homologous recombination. Nucleic Acids Res 2012; 40: 10312\u201310323.","journal-title":"Nucleic Acids Res"},{"key":"BFonc201746_CR10","doi-asserted-by":"publisher","first-page":"18302","DOI":"10.1074\/jbc.M109.016717","volume":"284","author":"SM Sy","year":"2009","unstructured":"Sy SM, Huen MS, Zhu Y, Chen J . PALB2 regulates recombinational repair through chromatin association and oligomerization. J Biol Chem 2009; 284: 18302\u201318310.","journal-title":"J Biol Chem"},{"key":"BFonc201746_CR11","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1158\/0008-5472.CAN-10-3958","volume":"71","author":"S Casadei","year":"2011","unstructured":"Casadei S, Norquist BM, Walsh T, Stray S, Mandell JB, Lee MK et al. Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer. Cancer Res 2011; 71: 2222\u20132229.","journal-title":"Cancer Res"},{"key":"BFonc201746_CR12","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/ng1947","volume":"39","author":"S Reid","year":"2007","unstructured":"Reid S, Schindler D, Hanenberg H, Barker K, Hanks S, Kalb R et al. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genet 2007; 39: 162\u2013164.","journal-title":"Nat Genet"},{"key":"BFonc201746_CR13","doi-asserted-by":"publisher","first-page":"5454","DOI":"10.1158\/0008-5472.CAN-12-1470","volume":"72","author":"T Popova","year":"2012","unstructured":"Popova T, Manie E, Rieunier G, Caux-Moncoutier V, Tirapo C, Dubois T et al. Ploidy and large-scale genomic instability consistently identify basal-like breast carcinomas with BRCA1\/2 inactivation. Cancer Res 2012; 72: 5454\u20135462.","journal-title":"Cancer Res"},{"key":"BFonc201746_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature17676","volume":"534","author":"S Nik-Zainal","year":"2016","unstructured":"Nik-Zainal S, Davies H, Staaf J, Ramakrishna M, Glodzik D, Zou X et al. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature 2016; 534: 47\u201354.","journal-title":"Nature"},{"key":"BFonc201746_CR15","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s10549-010-1195-2","volume":"126","author":"YC Ding","year":"2011","unstructured":"Ding YC, Steele L, Kuan CJ, Greilac S, Neuhausen SL . Mutations in BRCA2 and PALB2 in male breast cancer cases from the United States. Breast Cancer Res Treat 2011; 126: 771\u2013778.","journal-title":"Breast Cancer Res Treat"},{"key":"BFonc201746_CR16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/ng1942","volume":"39","author":"B Xia","year":"2007","unstructured":"Xia B, Dorsman JC, Ameziane N, de Vries Y, Rooimans MA, Sheng Q et al. Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat Genet 2007; 39: 159\u2013161.","journal-title":"Nat Genet"},{"key":"BFonc201746_CR17","doi-asserted-by":"publisher","first-page":"3764","DOI":"10.1158\/1078-0432.CCR-15-2477","volume":"22","author":"ML Telli","year":"2016","unstructured":"Telli ML, Timms KM, Reid JE, Hennessy B, Mills GB, Jensen KC et al. Homologous recombination deficiency (HRD) score predicts response to platinum-containing neoadjuvant chemotherapy in patients with triple negative breast cancer. Clin Cancer Res 2016; 22: 3764\u20133773.","journal-title":"Clin Cancer Res"},{"key":"BFonc201746_CR18","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1158\/1078-0432.CCR-13-2287","volume":"20","author":"KP Pennington","year":"2014","unstructured":"Pennington KP, Walsh T, Harrell MI, Lee MK, Pennil CC, Rendi MH et al. Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas. Clin Cancer Res 2014; 20: 764\u2013775.","journal-title":"Clin Cancer Res"},{"key":"BFonc201746_CR19","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1158\/2159-8290.CD-13-0011","volume":"3","author":"Y Huo","year":"2013","unstructured":"Huo Y, Cai H, Teplova I, Bowman-Colin C, Chen G, Price S et al. Autophagy opposes p53-mediated tumor barrier to facilitate tumorigenesis in a model of PALB2-associated hereditary breast cancer. Cancer Discov 2013; 3: 894\u2013907.","journal-title":"Cancer Discov"},{"key":"BFonc201746_CR20","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12916-015-0425-1","volume":"13","author":"L Livraghi","year":"2015","unstructured":"Livraghi L, Garber JE . PARP inhibitors in the management of breast cancer: current data and future prospects. BMC Med 2015; 13: 188.","journal-title":"BMC Med"},{"key":"BFonc201746_CR21","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nrc.2015.21","volume":"16","author":"CJ Lord","year":"2016","unstructured":"Lord CJ, Ashworth A . BRCAness revisited. Nat Rev Cancer 2016; 16: 110\u2013120.","journal-title":"Nat Rev Cancer"},{"key":"BFonc201746_CR22","doi-asserted-by":"publisher","first-page":"e1006236","DOI":"10.1371\/journal.pgen.1006236","volume":"12","author":"SA Hartford","year":"2016","unstructured":"Hartford SA, Chittela R, Ding X, Vyas A, Martin B, Burkett S et al. Interaction with PALB2 is essential for maintenance of genomic integrity by BRCA2. PLoS Genet 2016; 12: e1006236.","journal-title":"PLoS Genet"},{"key":"BFonc201746_CR23","doi-asserted-by":"publisher","first-page":"24617","DOI":"10.1074\/jbc.M114.566141","volume":"289","author":"S Simhadri","year":"2014","unstructured":"Simhadri S, Peterson S, Patel DS, Huo Y, Cai H, Bowman-Colin C et al. Male fertility defect associated with disrupted BRCA1-PALB2 interaction in mice. The J Biol Chem 2014; 289: 24617\u201324629.","journal-title":"The J Biol Chem"},{"key":"BFonc201746_CR24","doi-asserted-by":"publisher","first-page":"566","DOI":"10.7150\/ijbs.8579","volume":"10","author":"L Wang","year":"2014","unstructured":"Wang L, Di LJ . BRCA1 and estrogen\/estrogen receptor in breast cancer: where they interact? Int J Biol Sci 2014; 10: 566\u2013575.","journal-title":"Int J Biol Sci"},{"key":"BFonc201746_CR25","doi-asserted-by":"publisher","first-page":"6788","DOI":"10.1073\/pnas.0701724104","volume":"104","author":"M Tischkowitz","year":"2007","unstructured":"Tischkowitz M, Xia B, Sabbaghian N, Reis-Filho JS, Hamel N, Li G et al. Analysis of PALB2\/FANCN-associated breast cancer families. Proc Natl Acad Sci USA 2007; 104: 6788\u20136793.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc201746_CR26","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/ng.2969","volume":"46","author":"S Kohsaka","year":"2014","unstructured":"Kohsaka S, Shukla N, Ameur N, Ito T, Ng CK, Wang L et al. A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations. Nat Genet 2014; 46: 595\u2013600.","journal-title":"Nat Genet"},{"key":"BFonc201746_CR27","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/ng.2643","volume":"45","author":"AS Ho","year":"2013","unstructured":"Ho AS, Kannan K, Roy DM, Morris LG, Ganly I, Katabi N et al. The mutational landscape of adenoid cystic carcinoma. Nat Genet 2013; 45: 791\u2013798.","journal-title":"Nat Genet"},{"key":"BFonc201746_CR28","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/path.4675","volume":"238","author":"S Piscuoglio","year":"2016","unstructured":"Piscuoglio S, Burke KA, Ng CK, Papanastasiou AD, Geyer FC, Macedo GS et al. Uterine adenosarcomas are mesenchymal neoplasms. J Pathol 2016; 238: 381\u2013388.","journal-title":"J Pathol"},{"key":"BFonc201746_CR29","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R . Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009; 25: 1754\u20131760.","journal-title":"Bioinformatics"},{"key":"BFonc201746_CR30","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A et al. The Genome analysis toolkit: a mapreduce framework for analyzing next-generation DNA sequencing data. Genome Res 2010; 20: 1297\u20131303.","journal-title":"Genome Res"},{"key":"BFonc201746_CR31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","volume":"31","author":"K Cibulskis","year":"2013","unstructured":"Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, Sougnez C et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol 2013; 31: 213\u2013219.","journal-title":"Nat Biotechnol"},{"key":"BFonc201746_CR32","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1093\/bioinformatics\/bts271","volume":"28","author":"CT Saunders","year":"2012","unstructured":"Saunders CT, Wong WS, Swamy S, Becq J, Murray LJ, Cheetham RK . Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics 2012; 28: 1811\u20131817.","journal-title":"Bioinformatics"},{"key":"BFonc201746_CR33","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1101\/gr.129684.111","volume":"22","author":"DC Koboldt","year":"2012","unstructured":"Koboldt DC, Zhang Q, Larson DE, Shen D, McLellan MD, Lin L et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res 2012; 22: 568\u2013576.","journal-title":"Genome Res"},{"key":"BFonc201746_CR34","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1093\/nar\/gkw520","volume":"44","author":"R Shen","year":"2016","unstructured":"Shen R, Seshan VE . FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing. Nucleic Acids Res 2016; 44: e131.","journal-title":"Nucleic Acids Res"},{"key":"BFonc201746_CR35","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.1158\/1078-0432.CCR-15-2840","volume":"22","author":"S Piscuoglio","year":"2016","unstructured":"Piscuoglio S, Ng CK, Murray MP, Guerini-Rocco E, Martelotto LG, Geyer FC et al. The genomic landscape of male breast cancers. Clin Cancer Res 2016; 22: 4045\u20134056.","journal-title":"Clin Cancer Res"},{"key":"BFonc201746_CR36","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nbt.2203","volume":"30","author":"SL Carter","year":"2012","unstructured":"Carter SL, Cibulskis K, Helman E, McKenna A, Shen H, Zack T et al. Absolute quantification of somatic DNA alterations in human cancer. Nat Biotechnol 2012; 30: 413\u2013421.","journal-title":"Nat Biotechnol"},{"key":"BFonc201746_CR37","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature12213","volume":"499","author":"MS Lawrence","year":"2013","unstructured":"Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 2013; 499: 214\u2013218.","journal-title":"Nature"},{"key":"BFonc201746_CR38","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nmeth0810-575","volume":"7","author":"JM Schwarz","year":"2010","unstructured":"Schwarz JM, Rodelsperger C, Schuelke M, Seelow D . MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods 2010; 7: 575\u2013576.","journal-title":"Nat Methods"},{"key":"BFonc201746_CR39","doi-asserted-by":"publisher","first-page":"6660","DOI":"10.1158\/0008-5472.CAN-09-1133","volume":"69","author":"H Carter","year":"2009","unstructured":"Carter H, Chen S, Isik L, Tyekucheva S, Velculescu VE, Kinzler KW et al. Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations. Cancer Res 2009; 69: 6660\u20136667.","journal-title":"Cancer Res"},{"key":"BFonc201746_CR40","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/humu.22225","volume":"34","author":"HA Shihab","year":"2013","unstructured":"Shihab HA, Gough J, Cooper DN, Stenson PD, Barker GL, Edwards KJ et al. Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models. Hum Mutat 2013; 34: 57\u201365.","journal-title":"Hum Mutat"},{"key":"BFonc201746_CR41","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature12634","volume":"502","author":"C Kandoth","year":"2013","unstructured":"Kandoth C, McLellan MD, Vandin F, Ye K, Niu B, Lu C et al. Mutational landscape and significance across 12 major cancer types. Nature 2013; 502: 333\u2013339.","journal-title":"Nature"},{"key":"BFonc201746_CR42","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature12912","volume":"505","author":"MS Lawrence","year":"2014","unstructured":"Lawrence MS, Stojanov P, Mermel CH, Robinson JT, Garraway LA, Golub TR et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 2014; 505: 495\u2013501.","journal-title":"Nature"},{"key":"BFonc201746_CR43","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nrc1299","volume":"4","author":"PA Futreal","year":"2004","unstructured":"Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R et al. A census of human cancer genes. Nat Rev Cancer 2004; 4: 177\u2013183.","journal-title":"Nat Rev Cancer"},{"key":"BFonc201746_CR44","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4137\/CIN.S13495","volume":"13","author":"Y Hu","year":"2014","unstructured":"Hu Y, Yan C, Hsu CH, Chen QR, Niu K, Komatsoulis GA et al. OmicCircos: a simple-to-use r package for the circular visualization of multidimensional omics data. Cancer Inform 2014; 13: 13\u201320.","journal-title":"Cancer Inform"},{"key":"BFonc201746_CR45","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV et al. Signatures of mutational processes in human cancer. Nature 2013; 500: 415\u2013421.","journal-title":"Nature"},{"key":"BFonc201746_CR46","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.celrep.2012.12.008","volume":"3","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov LB, Nik-Zainal S, Wedge DC, Campbell PJ, Stratton MR . Deciphering signatures of mutational processes operative in human cancer. Cell Rep 2013; 3: 246\u2013259.","journal-title":"Cell Rep"},{"key":"BFonc201746_CR47","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"Cancer Genome Atlas Network","year":"2012","unstructured":"Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature 2012; 490: 61\u201370.","journal-title":"Nature"},{"key":"BFonc201746_CR48","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1002\/pros.20729","volume":"68","author":"M Tischkowitz","year":"2008","unstructured":"Tischkowitz M, Sabbaghian N, Ray AM, Lange EM, Foulkes WD, Cooney KA . Analysis of the gene coding for the BRCA2-interacting protein PALB2 in hereditary prostate cancer. Prostate 2008; 68: 675\u2013678.","journal-title":"Prostate"},{"key":"BFonc201746_CR49","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s10549-010-1290-4","volume":"126","author":"N Bogdanova","year":"2011","unstructured":"Bogdanova N, Sokolenko AP, Iyevleva AG, Abysheva SN, Blaut M, Bremer M et al. PALB2 mutations in German and Russian patients with bilateral breast cancer. Breast Cancer Res Treat 2011; 126: 545\u2013550.","journal-title":"Breast Cancer Res Treat"},{"key":"BFonc201746_CR50","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s10549-014-3260-8","volume":"149","author":"T Nguyen-Dumont","year":"2015","unstructured":"Nguyen-Dumont T, Hammet F, Mahmoodi M, Tsimiklis H, Teo ZL, Li R et al. Mutation screening of PALB2 in clinically ascertained families from the Breast Cancer Family Registry. Breast Cancer Res Treat 2015; 149: 547\u2013554.","journal-title":"Breast Cancer Res Treat"},{"key":"BFonc201746_CR51","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1002\/cncr.26388","volume":"118","author":"Y Zheng","year":"2012","unstructured":"Zheng Y, Zhang J, Niu Q, Huo D, Olopade OI . Novel germline PALB2 truncating mutations in African American breast cancer patients. Cancer 2012; 118: 1362\u20131370.","journal-title":"Cancer"},{"key":"BFonc201746_CR52","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10549-010-1271-7","volume":"126","author":"YC Ding","year":"2011","unstructured":"Ding YC, Steele L, Chu LH, Kelley K, Davis H, John EM et al. Germline mutations in PALB2 in African-American breast cancer cases. Breast Cancer Res Treat 2011; 126: 227\u2013230.","journal-title":"Breast Cancer Res Treat"},{"key":"BFonc201746_CR53","doi-asserted-by":"publisher","first-page":"R17","DOI":"10.1186\/bcr3392","volume":"15","author":"Z Teo","year":"2013","unstructured":"Teo Z, Park DJ, Provenzano E, Chatfield CA, Odefrey FA, Nguyen-Dumont T et al. Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families. Breast Cancer Res 2013; 15: R17.","journal-title":"Breast Cancer Res"},{"key":"BFonc201746_CR54","doi-asserted-by":"publisher","first-page":"e67538","DOI":"10.1371\/journal.pone.0067538","volume":"8","author":"A Blanco","year":"2013","unstructured":"Blanco A, de la Hoya M, Osorio A, Diez O, Miramar MD, Infante M et al. Analysis of PALB2 gene in BRCA1\/BRCA2 negative Spanish hereditary breast\/ovarian cancer families with pancreatic cancer cases. PLoS One 2013; 8: e67538.","journal-title":"PLoS One"},{"key":"BFonc201746_CR55","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/humu.22022","volume":"33","author":"M Tischkowitz","year":"2012","unstructured":"Tischkowitz M, Capanu M, Sabbaghian N, Li L, Liang X, Vall\u00e9e MP et al. Rare germline mutations in PALB2 and breast cancer risk: a population-based study. Hum Mutat 2012; 33: 674\u2013680.","journal-title":"Hum Mutat"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc201746","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc201746.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/onc.2017.46","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/onc201746.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T20:17:03Z","timestamp":1647893823000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc201746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,20]]},"references-count":55,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2017,7,20]]}},"alternative-id":["BFonc201746"],"URL":"https:\/\/doi.org\/10.1038\/onc.2017.46","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,20]]},"assertion":[{"value":"26 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}